Richardson DL, Quintanilha JCF, Danziger N, Li G, et al. Effectiveness of PARP inhibitor maintenance therapy in ovarian cancer by BRCA1/2 and a scar-based HRD signature in real-world practice. Clin Cancer Res 2024 Jul 30. doi: 10.1158/1078-0432.CCR-24-1225.
PMID: 39078736